Pharmacogenetics in Type 2 Diabetes Treatment.

• In: SIG Posters
• At: Amsterdam (the Netherlands) (2012)
• Type: Poster
• Poster code: TRI-05
• By: SEMIZ, Sabina (University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
• Co-author(s): Dujic, T. (University of Sarajevo, Sarajevo, Bosnia and Herzegovina)
  Causevic-Ramosevac, A. (Bosnalijek, Sarajevo, Bosnia and Herzegovina)
  Causevic, A. (University of Sarajevo, Sarajevo, Bosnia and Herzegovina)
  
• Abstract:

  Background: Type 2 diabetes (T2D) is a worldwide epidemic with considerable health and economic consequences. Diabetic patients are often treated with more than one oral antidiabetic drug (OAD), including metformin and sulfonylureas (SU). Genetic variations in drug-metabolizing enzymes (DME), drug-transporters (DT), and other specific drug targets

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login